Mental Health Clinics in Sedro Woolley, WA Accepting Medicare
9 Mental Health Clinics found. Showing 1 - 9
 North Sound Peer Bridger Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1803 N Sound Dr, Sedro Woolley, WA 98284 Phone: 360-854-7400 Fax: 360-854-7445 |
Upper Skagit Tribal Cd Clinic Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 25959 Community Plaza Way, Sedro Woolley, WA 98284 Phone: 360-854-7070 Fax: 360-854-7060 |
Sunrise Services, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 10212 Collins Rd, Sedro Woolley, WA 98284 Phone: 360-848-8615 |
Upper Skagit Tribal Clinic Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 25959 Community Plaza Way, Sedro Woolley, WA 98284 Phone: 360-854-7070 Fax: 360-854-7060 |
Telecare Mental Health Services Of Washington, Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1803 N Sound Dr, Sedro Woolley, WA 98284 Phone: 360-854-7400 Fax: 360-854-7445 |
Upper Skagit Tribal Mental Healthclinic Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 25959 Community Plaza Way, Sedro Woolley, WA 98284 Phone: 360-854-7070 |
Pioneer Human Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1960 Thompson Dr, Sedro Woolley, WA 98284 Phone: 360-856-3186 |
Isaac Ekblad Counseling Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 127 Abbotts Aly, Sedro Woolley, WA 98284 Phone: 360-603-0339 |
Kelsey Ellingson Watson, Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 557 Rainbow Dr, Sedro Woolley, WA 98284 Phone: 360-230-8346 |
News Archive
First genetic test on developing risk of Alzheimer's disease and heart attacks
Alzheimer and heart attacks have been found to share common genetic basis. The research leads the way to the first genetic test on developing the risk of the diseases even at a young age. According to Federico Licastro, an immunologist at the University of Bologna who coordinated the study published in the scientific journal, Journal of Alzheimer's Disease, a test is now ready. "They are already selling it in America", he says, citing the case of a private firm in New Mexico (USA) that collaborated on the study. "But the tests could easily be also conducted wherever, using a simple blood test".
Encouraging results from CTI's pacritinib phase 1 study on relapsed/refractory lymphoma
Cell Therapeutics, Inc. announced today that the phase 1 study data of its highly selective oral JAK2 inhibitor pacritinib, or SB1518, showed encouraging anti-tumor activity and good tolerability in 34 patients with relapsed/refractory lymphoma.
3D cultured spheroids could drive precision treatment for ovarian cancer
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.
› Verified 3 days ago